Neuroprotective effects of tetracyclines on blunt head trauma: An experimental study on rats

Journal of Neurosciences in Rural Practice

Volumn 6, Issue 1, 2015, Pages 27-32

  Uckun, Ozhan Merzuk ^a   Alagoz, Fatih ^b   Secer, Mehmet ^c   Karakoyun, Oguz ^c   Ocakcioglu, Ayhan ^d   Yildirim, Ali Erdem ^b   Yilmaz, Fevzi ^b   Sahinoglu, Mert ^b   Divanlioglu, Denizhan ^b   Dalgic, Ali ^b   Daglioglu, Ergun ^b   Belen, Ahmet Deniz ^b  

^a Yunus Emre State Hospital   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c Neurosurgery Clinics Sahit Kamil State Hospital   (Turkey)

^d Afsin State Hospital   (Turkey)

Author keywords

Lipid peroxidation; Neuroprotection; Rat head trauma; Secondary brain injury; Tetracycline

Indexed keywords

KETAMINE; TETRACYCLINE DERIVATIVE; XYLAZINE;

ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLUNT TRAUMA; BRAIN EDEMA; CONTROLLED STUDY; CRANIECTOMY; DEGENERATION; HEAD INJURY; LIPID PEROXIDATION; MALE; MITOCHONDRION; MYELINATION; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RAT; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84908520920     PISSN: 09763147     EISSN: 09763155     Source Type: Journal    
DOI: 10.4103/0976-3147.143186     Document Type: Article

References (38)

1. Saveren M. Altinors N, Baykaner K, Sekerci Z, Ozyurt E, Caner H, editors. Traumatic Cranaial Injury. Basic Neurosurgery 1. Ankara: Turkish Neuorsurgery Society; 1997. p. 1-9.
2. Neuwelt EA, Coe MF, Wilkinson AM, Avoloio AE. Oregon head and spinal cord injury prevention program and evaluation. Neurosurgery 1989;24:453-8.
3. Campbell JW, Adelson PD. Severe closed head injury in children. In: Batjer HH, Loftus CM, editors. Textbook of Neurological surgery. Baltimore, USA: Lippincott, Williams and Wilkins; 2002. p. 1072-8.
4. Greenberg MS. Handbook of Neurosurgery. New York: Thieme; 2001. p. 677-9.
5. Rivara FP. Pediatric injury control in 1999: Where do we go from here? Pediatrics 1999;103: 883-8.
6. Basic Neurosurgery. Section 1, Turkish Neuorsurgery Society 2005. p. 298-299.
7. Gennarelli TA, Meaney DF. Mechanisms of primary head injury. In: Wilkins RH, Rengachary SS, editors. Neurosurgery. 2nd ed. New York: McGraw-Hill; 1996. p. 2611-21.
8. Miller JD. Pathophysiology of human head injury. In: Becker DP, Gudeman SK, editors. Textbook of Head Injury. Philadelphia: WB Saunders; 1989. p. 507-24.
9. Fehlings MG, Tator CH. The effect of direct current field polarity on recovery after acute experimental spinal cord injury. Brain Res 1992;579:32-42.
10. Fink KB, Andrews LJ, Butler WE, Ona VO, Li M, Bogdanov M, et al. Reduction of post raumatic brain injury and free radical production by inhibition of the caspase-1 cascade. Neuroscience 1999;94:1213-8.
11. Friedlander RM, Gagliardini V, Rotello RJ, Yuan J. Functional role of interleukin 1beta (IL-1beta) in IL-1beta-converting enzyme-mediated apoptosis. J Exp Med 1996;184:717-24.
12. Troy CM, Stefanis L, Prochiantz A, Greene La, Shelanski ML. The contrasting roles of ICE family proteases and interleukin-1beta in apoptosis induced by trophic factor withdrawal and by copper/zinc superoxide dismutase down-regulation. Proc Natl Acad Sci U S A 1996;93:5635-40.
13. Yrjänheikki J, Keinänen R, Pellikka M, Hökfelt T, Koistinaho J. Tetracyclines inhibit micro glial activation and are neuro protective in global brain ischemia. Proc Natl Acad Sci USA 1998;95:15769-74.
14. Wells JE, Hurlbert RJ, Fehlings MG, Yong VW. Neuro protection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain 2003;126:1628-37.
15. Yang L, Sugama S, Chirichigno, JW, Gregorio J, Lorenzl S, Shin DH, et al. Minocycline enhances MPTP toxicity to dopaminergic neurons. J Neurosci Res 2003;74:278-85.
16. Tator CH, Hashimoto R, Raich A, Norvell D, Fehlings MG, Harrop JS, et al. Translational potential of preclinical trials of neuroprotection through pharmacotherapy for spinal cord injury. J Neurosurg Spine 2012;17(Suppl):157-229.
17. Homsi S, Piaggio T, Croci N, Noble F, Plotkine M, Marchand-Leroux C, et al. Blockade of acute microglial activation by minocycline promotes neuroprotection and reduces locomotor hyperactivity after closed head injury in mice: A twelve-week follow-up study. J Neurotrauma 2010;27:911-21.
18. Saganová K, Orendácová J, Cízková D, Vanický I. Limited minocycline neuroprotection after balloon-compression spinal cord injury in the rat. Neurosci Lett 2008;433:246-9.
19. von Gertten C, Flores Morales A, Holmin S, Mathiesen T, Nordqvist AC. Genomic responses in rat cerebral cortex after traumatic brain injury. BMC Neurosci 2005;6:69.
20. Feeney DM, Boyeson MG, Linn RT, Murray HM, Dail WG. Responses to cortical injur: I. Methodology and local effects of contusions in the rat. Brain Res 1981;211:67-77.
21. Liao TV, Forehand CC, Hess DC, Fagan SC. Minocycline repurposing in critical illness: Focus on stroke. Curr Top Med Chem 2013;13:2283-90.
22. Mihara M, Uchiyama M. Determination of malonaldehyde precursors in tissues by thiobarbituric acid test. Ann Bio chem 1978;86:271-8.
23. Graham DI, Adams JH, Doyle D, Ford I, Gennarelli TA, Lawrence AE, et al. Quantification of primary and secondary lesions in severe head injury. Acta Neurochir Suppl (Wien) 1993;57:41-8.
24. Shapira Y, Lam AM, Eng CC, Laohaprasit V, Michel M. Therapeutic time window and dose responce of the beneficial effects of ketamine in experimental head injury. Stroke 1994;25:1637-43.
25. Hubschmann OR, Nathanson DC. The role of calcium and cellular membrane dysfunction in experimental trauma and subarachnoid hemorrhage. J Neurosurg 1985;62:698-703.
26. Ishige N, Pitts LH, Hashimoto T, Nishimura MC, Bartkowski HM. Effect of hypoxia on traumatic brain injury in rats: Part 1. Changes in neurological function, electroencephalograms, and histopathology. Neurosurgery 1987;20:848-53.
27. Bullock R, Kuroda Y, Teasdale GM, McCulloch J. Prevention of post-traumatic excitotoxic brain damage with NMDA antagonist drugs: A new strategy for the nineties. Acta Neurochir Suppl (Wien) 1992;55:49-55.
28. Nicholls D, Attwell D. The release and uptake of excitatory amino acids. Trends Pharmacol Sci 1990;11:462-8.
29. Chen HS, Pellegrini JW, Aggarwal SK, Lei SZ, Warach S, Jensen FE, et al. Open-channel block N-methyl-D-aspartate (NMDA) responses by memantine: Theropeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 1992;12:4427-36.
30. Becker DP, Gudeman SK. Acut head injury: Assesment, management and prognosis. In: Hardy JD, editor. Critical Surgical Illness. 2nd ed. Philadelphia: WB Saunders; 1980. p. 110-34.
31. Lam AM, Winn HR, Cullen BF, Sundling NS. Hyperglycemia and neurological outcome in patients with head injury. J Neurosurg 1991;75:545-51.
32. Robertson CS, Goodman JC, Narayan RK, Contant CF, Grossman RG. The effect of glucose administration on carbohydrate metabolism after head injury. J Neurosurg 1991;74:43-50.
33. Yrjänheikki J, Tikka T, Keinänen R, Goldsteins G, Chan PH, Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapatic window. Proc Natl Acad Sci U S A 1999;96:13496-500.
34. Lazzarini M, Martin S, Mitkovski M, Vozari RR, Stühmer W, Bel ED. Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model. Glia 2013;61:1084-100.
35. Koistinaho J, Yrjänheikki J, Kauppinen T, Koistinaho M. Tetracycline derivatives as anti-inflammatory agents and potential agents in stroke treatment. Ernst Schering Res Found Workshop 2004;101-15.
36. Tikka T, Usenius T, Tenhunen M, Keinänen R, Koistinaho J. Tetracycline derivatives and ceftriaxone, a cephalosporin antibiotic, protect neurons against apoptosis induced by ionizing radiation. J Neurochem 2001;78:1409-14.
37. Cai Z, Yan Y, Wang Y. Minocycline alleviates beta-amyloid protein and tau pathology via restraining neuroinflammation induced by diabetic metabolic disorder. Clin Interv Aging 2013;8:1089-95.
38. Kraus RL, Pasieczny R, Lariosa-Willingham K, Turner MS, Jiang A. Trauger JW. Antioxidant properties of minocycline: Neuroprotection in an oxidative stress assay and direct radical-scavenging activity. J Neurochem 2005;94:819-27.